Prohibiting Foreign Access to American Genetic Information Act of 2024

10/10/2024, 9:41 PM
Congress
118

Number
S - 3558

Introduced on
2023-12-20

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

9/23/2024

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

This bill prohibits federal contracting with certain biotechnology providers connected to foreign adversaries, with exceptions.

Specifically, the bill prohibits executive agencies from (1) procuring or obtaining any biotechnology equipment or service produced or provided by a biotechnology company of concern, or (2) entering into a contract or extending or renewing a contract that uses such equipment or service or that will require the direct use of such equipment or services. Those agencies may not obligate or expend loan or grant funds for such purposes.

A biotechnology company of concern includes BGI, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of such entities, and any entity that

  • is subject to the jurisdiction, direction, control, or operates on behalf of the government of a foreign adversary;
  • is involved in the manufacturing, distribution, provision, or procurement of a biotechnology equipment or service; and
  • poses a risk to U.S. national security based on specified activities.

Executive agencies may waive the prohibitions on a case-by-case basis under specified circumstances.

The Office of Management and Budget must develop and periodically update a list of the entities that constitute biotechnology companies of concern.

Bill 118 s 3558, also known as the Prohibiting Foreign Access to American Genetic Information Act of 2024, aims to protect the genetic information of American citizens from being accessed by foreign entities. The bill prohibits any foreign government, organization, or individual from obtaining or accessing genetic information of Americans without their explicit consent.

The legislation highlights the importance of safeguarding genetic data, as it contains sensitive and personal information that could be used for malicious purposes. By restricting foreign access to American genetic information, the bill seeks to prevent potential breaches of privacy and security.

Furthermore, the bill outlines strict penalties for those found in violation of the law, including hefty fines and potential imprisonment. It also establishes a framework for monitoring and enforcing compliance with the regulations set forth in the legislation. Overall, the Prohibiting Foreign Access to American Genetic Information Act of 2024 is a proactive measure aimed at protecting the privacy and security of American citizens in an increasingly digital and interconnected world.
Alternative Names
Official Title as IntroducedA bill to prohibit contracting with certain biotechnology providers, and for other purposes.

Policy Areas
Government Operations and Politics

Potential Impact
Congressional oversight
Government information and archives
Health technology, devices, supplies
Public contracts and procurement

Comments

Recent Activity

Latest Summary2/6/2024

This bill prohibits federal contracting with certain biotechnology providers connected to foreign adversaries, with exceptions.

Specifically, the bill prohibits executive agencies from (1) procuring or obtaining any biotechnology equipment ...


Latest Action9/23/2024
Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.